-- Announcement on Obtaining Notice of Approval for Re-Registration of Drug by Wholly-owned Subsidiary

Securities code: 600671 Securities abbreviation: Tianmu Pharmaceutical Announcement number: Lin 2025-042 Hangzhou Tianmushan Pharmaceutical Co., Ltd.

Announcement on the receipt of drug re-registration approval notice by a wholly-owned subsidiary

The company's board of directors and all directors guarantee that the contents of this announcement do not contain any false records, misleading statements or major omissions, and assume legal responsibility for the authenticity, accuracy and completeness of its contents.

Hangzhou Tianmushan Pharmaceutical Co., Ltd. (hereinafter referred to as the "Company") learned that Huangshan Tianmu Pharmaceutical Co., Ltd. (hereinafter referred to as "Huangshan Tianmu"), a wholly-owned subsidiary of the company, recently received the "Drug Re-registration Approval Notice" approved and issued by the Anhui Provincial Food and Drug Administration. The relevant information is now announced as follows:

1. Basic information on drugs

Medicines

Preface Product Drug Production Drug Registration Drug Registration

Dosage form Specification Notification number Approval number Indications

No. Name Manufacturer Approval No. Classification Standard No.

Validity period

Pills nourish yin and nourish the kidneys. For kidney yin deficiency, Liuweidi Huangshan per bottle, Chinese Pharmacopoeia until 2030

1 (water honey, traditional Chinese medicine 2025R068185 dizziness, tinnitus, soreness and weakness in waist and knees, Guhuang Pill Tianmu 36g Z34020569 2020 Edition 1 November 11

Pills) Steaming hot flashes, night sweats and spermatorrhea, quenching thirst. Pills: 8 pills per pill according to "Chinese Pharmacopoeia" Nourishing yin and nourishing the kidneys. For kidney yin deficiency, Liuwei Di Huangshan is approved as a national medicine by 2030.

2 (concentrated equivalent to the original drug, Chinese medicine No. 1 in the 2020 edition 2025R068186 Dizziness, tinnitus, soreness and weakness in the waist and knees, Guhuang Pill Tianmu Z34020368 November 15

Pills) Material 3g Supplement This book can cure hot flashes, night sweats and nocturnal emissions, and relieve thirst.

Regulates qi, activates blood circulation and relieves pain. Used for Yuanhuzhi Huangshan Each capsule Approved by the Chinese Pharmacopoeia until 2030

3 capsules Traditional Chinese Medicine 2025R068187 Capsules for stomach pain, hypochondriac pain, and pain caused by qi stagnation and blood stasis Tianmu 0.3g Z34020573 2020 Edition 1 November 22

Headache and dysmenorrhea.

Pills: Each 8 pill form nourishes the kidneys and liver. For liver and kidney yin deficiency, Qiju Huangshan National Drug Approval "Chinese Pharmacopoeia" until 2030

4 (Condensed equivalent to native Chinese medicine 2025R068552 Dizziness, tinnitus, shyness and photophobia, Yingdihuang Pill Tianmu Z34020575 2020 Edition 1 November 15

Pills) Medicine 3g Tears shed due to wind and blurred vision.

Relieve superficial dampness, regulate qi and harmonize the middle. Use pills. Each 8-pill package contains standard Chinese medicine ingredients issued by the Ministry of Medicine.

Huoxiang Huangshan National Medicine Approval by 2030 For external wind-cold and internal injury due to dampness, 5 (concentrated equivalent to native Chinese medicine Preparations Volume 7 2025R074036

Zhengqi Pills Tianmu Z34020337 November 15th: Severe headache and dizziness, chest and diaphragm tightness, epigastric pills) 3 grams of medicine WS3-B-1465-93

Abdominal distension and pain, vomiting and diarrhea.

Tonify the middle and replenish qi, raise Yang and lift depression. Use pills. Each 8-pill package contains standard Chinese medicine ingredients issued by the Ministry of Medicine.

Buzhong Huangshan National Medicine Approval by 2030 For weak spleen and stomach, subsidence of middle qi, 6 (concentrated equivalent to native Chinese medicine Preparations Volume 7 2025R074037

Yiqi Pills Tianmu Z34020364 November 15th: Tiredness, lack of food, bloating, long pills) medicine 3g WS3-B-1347-93

Diarrhea, anal prolapse, uterine prolapse.

Pills nourish the kidneys, nourish the liver, and improve eyesight. used for

Mingmu Huangshan Each Bottle National Drug Approval "Chinese Pharmacopoeia" Until 2030

7 (water honey, traditional Chinese medicine 2025R074068 Liver and kidney yin deficiency, astringent eyes and photophobia, Shidihuang Pill Tianmu 36 grams Z34020328 2020 Edition 1 August 04

Pills) Things are blurry and I shed tears in the wind. Pills nourish the kidneys and liver. Used for liver and kidney yin deficiency,

Qi Ju Huangshan per bottle National Drug Approval "Chinese Pharmacopoeia" until 2030

8 (water honey, traditional Chinese medicine 2025R074069 Dizziness, tinnitus, photophobia, Yingdihuang Pill Tianmu 36g Z34020576 2020 Edition 1 August 04

Pill) The wind sheds tears and the vision is blurred. Ministry-issued standard traditional Chinese medicine

Preparations Volume 19

Clearing away heat and detoxifying, relieving cough, eliminating phlegm,

Muscles and Bones Huangshan Each capsule National Drug Approval No. WS3-B3704-98, until 2030

9 capsules Traditional Chinese Medicine 2025R077906 Antiasthmatic. For acute and chronic bronchitis capsule Tianmu 0.45g Z34020366 National Drug Standard November 15

Tractitis, lung abscess.

(Revised) Promulgation

ZGB2005-15

Note: When the production of the above-mentioned drugs resumes, an on-site inspection application must be submitted to the Anhui Provincial Food and Drug Administration, and a batch of products must be inspected and qualified before they can be put on the market.

2. Impact on the company

The acquisition of the "Re-registration Approval Notice" for the above-mentioned drugs ensures the stability and continuation of the company's drug production and sales qualifications, and has positive significance for the company's subsequent production, sales, and promotion. The company will carry out pharmaceutical production in strict accordance with the requirements, control product quality, and continue to provide high-quality products to the market. Investors are advised to make prudent decisions and pay attention to investment risks.

Announcement is hereby made.

Board of Directors of Hangzhou Tianmushan Pharmaceutical Co., Ltd.

September 23, 2025